An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 021146
Company: HOSPIRA

Products on NDA 021146

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ATROPINE SULFATE	ATROPINE SULFATE	0.5MG/5ML (0.1MG/ML)	SOLUTION;INTRAVENOUS	Prescription	AP	Yes	Yes
ATROPINE SULFATE	ATROPINE SULFATE	0.25MG/5ML (0.05MG/ML)	SOLUTION;INTRAVENOUS	Prescription	AP	Yes	Yes
ATROPINE SULFATE	ATROPINE SULFATE	1MG/10ML (0.1MG/ML)	SOLUTION;INTRAVENOUS	Prescription	AP	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 021146

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
07/09/2001	ORIG-1	Approval	Type 5 - New Formulation or New Manufacturer	STANDARD	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-146_Atropine%20Sulfate_prntlbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-146_Atropine%20Sulfate_Approv.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-146_Atropine.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/30/2020	SUPPL-25	Manufacturing (CMC)-Packaging	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021146Orig1s025lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021146Orig1s025ltr.pdf
06/24/2020	SUPPL-22	Labeling-Container/Carton Labels, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021146Orig1s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021146Orig1s022ltr.pdf
11/01/2017	SUPPL-19	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021146s019lbl.pdf
08/17/2017	SUPPL-18	Manufacturing (CMC)-Control	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021146s018lbl.pdf
01/31/2017	SUPPL-16	Labeling-Container/Carton Labels	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/021146Orig1s016ltr.pdf
10/30/2015	SUPPL-15	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021146s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021146Orig1s015ltr.pdf
03/12/2014	SUPPL-14	Manufacturing (CMC)		Label is not available on this site.

Labels for NDA 021146

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/30/2020	SUPPL-25	Manufacturing (CMC)-Packaging	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021146Orig1s025lbl.pdf
06/24/2020	SUPPL-22	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021146Orig1s022lbl.pdf
06/24/2020	SUPPL-22	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021146Orig1s022lbl.pdf
11/01/2017	SUPPL-19	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021146s019lbl.pdf
08/17/2017	SUPPL-18	Manufacturing (CMC)-Control	Label (PDF)	This supplement type does not usually require new labeling.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021146s018lbl.pdf
10/30/2015	SUPPL-15	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021146s015lbl.pdf
07/09/2001	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-146_Atropine%20Sulfate_prntlbl.pdf

Therapeutic Equivalents for NDA 021146

ATROPINE SULFATE

SOLUTION;INTRAVENOUS; 0.5MG/5ML (0.1MG/ML)
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ATROPINE SULFATE	ATROPINE SULFATE	0.5MG/5ML (0.1MG/ML)	SOLUTION;INTRAVENOUS	Prescription	No	AP	212868	ACCORD HLTHCARE
ATROPINE SULFATE	ATROPINE SULFATE	0.5MG/5ML (0.1MG/ML)	SOLUTION;INTRAVENOUS	Prescription	No	AP	215342	AMNEAL
ATROPINE SULFATE	ATROPINE SULFATE	0.5MG/5ML (0.1MG/ML)	SOLUTION;INTRAVENOUS	Prescription	Yes	AP	021146	HOSPIRA

SOLUTION;INTRAVENOUS; 0.25MG/5ML (0.05MG/ML)
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ATROPINE SULFATE	ATROPINE SULFATE	0.25MG/5ML (0.05MG/ML)	SOLUTION;INTRAVENOUS	Prescription	No	AP	212868	ACCORD HLTHCARE
ATROPINE SULFATE	ATROPINE SULFATE	0.25MG/5ML (0.05MG/ML)	SOLUTION;INTRAVENOUS	Prescription	Yes	AP	021146	HOSPIRA

SOLUTION;INTRAVENOUS; 1MG/10ML (0.1MG/ML)
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ATROPINE SULFATE	ATROPINE SULFATE	1MG/10ML (0.1MG/ML)	SOLUTION;INTRAVENOUS	Prescription	No	AP	212868	ACCORD HLTHCARE
ATROPINE SULFATE	ATROPINE SULFATE	1MG/10ML (0.1MG/ML)	SOLUTION;INTRAVENOUS	Prescription	No	AP	215342	AMNEAL
ATROPINE SULFATE	ATROPINE SULFATE	1MG/10ML (0.1MG/ML)	SOLUTION;INTRAVENOUS	Prescription	Yes	AP	021146	HOSPIRA
ATROPINE SULFATE	ATROPINE SULFATE	1MG/10ML (0.1MG/ML)	SOLUTION;INTRAVENOUS	Prescription	No	AP	212461	INTL MEDICATION SYS
ATROPINE SULFATE	ATROPINE SULFATE	1MG/10ML (0.1MG/ML)	SOLUTION;INTRAVENOUS	Prescription	No	AP	214970	MEDEFIL INC

Top